CID 137304912

Pre-pseudomonine

Structural Information

Molecular Formula
C16H18N4O4
SMILES
C[C@@H]1[C@H](N=C(O1)C2=CC=CC=C2O)C(=O)N(CCC3=CN=CN3)O
InChI
InChI=1S/C16H18N4O4/c1-10-14(16(22)20(23)7-6-11-8-17-9-18-11)19-15(24-10)12-4-2-3-5-13(12)21/h2-5,8-10,14,21,23H,6-7H2,1H3,(H,17,18)/t10-,14+/m1/s1
InChIKey
VUWQVSPTFMKLPM-YGRLFVJLSA-N
Compound name
(4S,5R)-N-hydroxy-2-(2-hydroxyphenyl)-N-[2-(1H-imidazol-5-yl)ethyl]-5-methyl-4,5-dihydro-1,3-oxazole-4-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

330.1328 Da
Monoisotopic Mass

0.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 331.140076 174.5
[M+Na]+ 353.122018 180.2
[M-H]- 329.125524 179.5
[M+NH4]+ 348.166623 184.4
[M+K]+ 369.095958 177.9
[M+H-H2O]+ 313.130060 165.4
[M+HCOO]- 375.131001 191.9
[M+CH3COO]- 389.146651 205.1
[M+Na-2H]- 351.107466 173.6
[M]+ 330.13225142 174.6
[M]- 330.13334858 174.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.